You are here

Zhejiang Hisun Pharma

Pfizer exits China joint venture for generic drugs

Yahoo/Reuters

Fri, 11/10/17 - 10:25 pm

Zhejiang Hisun Pharma

China’s diabetes boom promises $23 billion pot for drug makers

Marketwatch

Fri, 01/15/16 - 02:30 pm

Zhejiang Hisun Pharma

China Biotech Week In Review: Pfizer's Attempt To Acquire AstraZeneca Could Run Into Trouble

Seeking Alpha

Sun, 05/4/14 - 11:44 am

Zhejiang Hisun Pharma

Sinovac Biotech

Hutchison MediPharma

TaiGen Biotechnology

WuXi PharmaTech

Concord Medical Services

China Biotech In Review: Unnamed Entity Raises Chindex Bid To $23

Seeking Alpha

Sun, 04/20/14 - 09:31 am

Changchun BCHT Biotechnology

Zhejiang Hisun Pharma

China Biotech In Review: Despite Its China Problems, GlaxoSmithKline Moving Forward With Vaccine Collaboration Plan

Seeking Alpha

Sun, 07/28/13 - 11:15 am

Zhejiang Hisun Pharma

China Biotech In Review: Cardinal Health Uses M&A To Add Drug Distribution Reach

Seeking Alpha

Sun, 02/10/13 - 11:30 am

Cardinal Health

Zhejiang Hisun Pharma

Grandhope Biotech

CVie Therapeutics

China Biotech In Review: 2012 China Life Science VC, M&A, And Partnering Climb

Seeking Alpha

Sun, 01/27/13 - 11:11 am

Zhejiang Hisun Pharma

Chongqing Huapont Pharma

Pfizer, Merck Ink Deals In China To Make Up For Shrinking Revenue

Seeking Alpha

Thu, 09/27/12 - 11:34 am

Zhejiang Hisun Pharma

Pfizer And Hisun Announce Launch Of Hisun-Pfizer Pharmaceuticals Co., Ltd.

Yahoo

Thu, 09/13/12 - 09:29 am

Zhejiang Hisun Pharma

Hisun-Pfizer Pharmaceuticals

China Biotech Week In Review: J&J Actively Pursuing M&A In China

Seeking Alpha

Sun, 05/20/12 - 12:33 pm

China National Biotech Group

Zhejiang Conba Pharma

Ningbo David Medical Device Co

Ventac Partners

Shanxi Zhendong Pharmaceutical Company

Bristol-Myers Squibb

Novozymes Biopharma

Zhejiang Hisun Pharma